{
  "ticker": "CRL",
  "year": 2023,
  "quarter": 3,
  "last_updated": "2025-04-15T15:30:14.989776",
  "count": 7,
  "transactions": [
    {
      "id": 123374,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-24",
      "transaction_shares": "1000",
      "transaction_price": "198.786",
      "transaction_type": "P",
      "shares_after_transaction": "1000"
    },
    {
      "id": 123326,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-08-10",
      "transaction_shares": "700",
      "transaction_price": "216.52",
      "transaction_type": "S",
      "shares_after_transaction": "24983"
    },
    {
      "id": 123363,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-08-10",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "197023"
    },
    {
      "id": 123370,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-08-10",
      "transaction_shares": "1471",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "11411"
    },
    {
      "id": 123383,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-08-10",
      "transaction_shares": "5763",
      "transaction_price": "217.24",
      "transaction_type": "S",
      "shares_after_transaction": "3592"
    },
    {
      "id": 80756,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-03",
      "transaction_shares": "95",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11600"
    },
    {
      "id": 123341,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-03",
      "transaction_shares": "95",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11600"
    }
  ]
}